A federal lawsuit is accusing three of the biggest drug manufacturers of insulin of conspiring together to raise their prices, but the pharmaceutical companies deny the allegations. The lawsuit, filed on in January in a federal court in Massachusetts, said Sanofi SA, Novo Nordisk and Eli Lilly & Co simultaneously hiked the price of the drug. Investment research firm SSR Health analyzed list …
The Pawar Law Group announces a class action lawsuit on behalf of Novo Nordisk A/S. (“Novo Nordisk” or the “Company”) (NVO) investors who purchased Novo Nordisk between April 30, 2015 and October 27, 2016, inclusive (the “Class Period”). The suit is for recovery of investor losses.
Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO ) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, and docketed under 17-cv-00506, is on behalf of a class consisting of all persons or entities who …